Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Davide Capodanno
Stephan Windecker

Showing results (271-280 of 2,160) with videos related to

Pageof 216
Sort By:
JAMA Cardiology|January 6, 2021
Assessing the Risks of Bleeding vs Thrombotic Events in Patients at High Bleeding Risk After Coronary Stent Implantation: The ARC-High Bleeding Risk Trade-off ModelPhilip Urban, John Gregson, Ruth Owen, et al.
Nature Reviews. Cardiology|August 24, 2021
Bleeding avoidance strategies in percutaneous coronary interventionDavide Capodanno, Deepak L Bhatt, C Michael Gibson, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|May 17, 2014
Unmet needs of young interventional cardiologists: proceedings from the 2nd summit of the European association of percutaneous cardiovascular interventionsDavide Capodanno, Gregory Ducrocq, Gabor Toth, et al.
Heart (British Cardiac Society)|October 13, 2010
TAVI as a threat to surgical practice: "much ado about nothing" or "the quiet before the storm"?Corrado Tamburino, Davide Capodanno, Gian Paolo Ussia
Nature Reviews. Cardiology|August 5, 2016
Antithrombotic therapy for secondary prevention of atherothrombotic events in cerebrovascular diseaseDavide Capodanno, Mark Alberts, Dominick J Angiolillo
Therapeutic Advances in Cardiovascular Disease|December 10, 2019
Evolving paradigms in antithrombotic therapy for anticoagulated patients undergoing coronary stentingSergio Buccheri, Dominick J Angiolillo, Davide Capodanno
Expert Opinion on Drug Safety|December 4, 2023
Bleeding in acute coronary syndrome: from definitions, incidence, and prognosis to prevention and managementClaudio Laudani, Davide Capodanno, Dominick Joseph Angiolillo
European Heart Journal Supplements : Journal of the European Society of Cardiology|May 8, 2026
Early discontinuation of acetylsalicylic acid after angioplasty in acute coronary syndromes: the NEO-MINDSET and TARGET-FIRST studiesGiacinto Di Leo, Diego Nastasi, Davide Capodanno
Expert Review of Cardiovascular Therapy|July 15, 2020
An updated drug profile of ticagrelor with considerations on the treatment of patients with coronary artery disease and diabetes mellitusDario Calderone, Davide Capodanno, Dominick J Angiolillo
Expert Opinion on Pharmacotherapy|July 24, 2024
The pharmacology of antiplatelet agents for primary, secondary, and tertiary prevention of ischemic strokeClaudio Laudani, Davide Capodanno, Dominick J Angiolillo
Pageof 216

Showing results (271-280 of 2,160) with videos related to

Sort By:
Pageof 216
JAMA Cardiology|January 6, 2021
Assessing the Risks of Bleeding vs Thrombotic Events in Patients at High Bleeding Risk After Coronary Stent Implantation: The ARC-High Bleeding Risk Trade-off ModelPhilip Urban, John Gregson, Ruth Owen, et al.
Nature Reviews. Cardiology|August 24, 2021
Bleeding avoidance strategies in percutaneous coronary interventionDavide Capodanno, Deepak L Bhatt, C Michael Gibson, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|May 17, 2014
Unmet needs of young interventional cardiologists: proceedings from the 2nd summit of the European association of percutaneous cardiovascular interventionsDavide Capodanno, Gregory Ducrocq, Gabor Toth, et al.
Heart (British Cardiac Society)|October 13, 2010
TAVI as a threat to surgical practice: "much ado about nothing" or "the quiet before the storm"?Corrado Tamburino, Davide Capodanno, Gian Paolo Ussia
Nature Reviews. Cardiology|August 5, 2016
Antithrombotic therapy for secondary prevention of atherothrombotic events in cerebrovascular diseaseDavide Capodanno, Mark Alberts, Dominick J Angiolillo
Therapeutic Advances in Cardiovascular Disease|December 10, 2019
Evolving paradigms in antithrombotic therapy for anticoagulated patients undergoing coronary stentingSergio Buccheri, Dominick J Angiolillo, Davide Capodanno
Expert Opinion on Drug Safety|December 4, 2023
Bleeding in acute coronary syndrome: from definitions, incidence, and prognosis to prevention and managementClaudio Laudani, Davide Capodanno, Dominick Joseph Angiolillo
European Heart Journal Supplements : Journal of the European Society of Cardiology|May 8, 2026
Early discontinuation of acetylsalicylic acid after angioplasty in acute coronary syndromes: the NEO-MINDSET and TARGET-FIRST studiesGiacinto Di Leo, Diego Nastasi, Davide Capodanno
Expert Review of Cardiovascular Therapy|July 15, 2020
An updated drug profile of ticagrelor with considerations on the treatment of patients with coronary artery disease and diabetes mellitusDario Calderone, Davide Capodanno, Dominick J Angiolillo
Expert Opinion on Pharmacotherapy|July 24, 2024
The pharmacology of antiplatelet agents for primary, secondary, and tertiary prevention of ischemic strokeClaudio Laudani, Davide Capodanno, Dominick J Angiolillo
Pageof 216